120 related articles for article (PubMed ID: 25201044)
1. Systemic levels of CCL2, CCL3, CCL4 and CXCL8 differ according to age, time period and season among children newly diagnosed with type 1 diabetes and their healthy siblings.
Thorsen SU; Eising S; Mortensen HB; Skogstrand K; Pociot F; Johannesen J; Svensson J;
Scand J Immunol; 2014 Dec; 80(6):452-61. PubMed ID: 25201044
[TBL] [Abstract][Full Text] [Related]
2. Altered chemokine levels in individuals at risk of Type 1 diabetes mellitus.
Hanifi-Moghaddam P; Kappler S; Seissler J; Müller-Scholze S; Martin S; Roep BO; Strassburger K; Kolb H; Schloot NC
Diabet Med; 2006 Feb; 23(2):156-63. PubMed ID: 16433713
[TBL] [Abstract][Full Text] [Related]
3. Few differences in cytokines between patients newly diagnosed with type 1 diabetes and their healthy siblings.
Svensson J; Eising S; Hougaard DM; Mortensen HB; Skogstrand K; Simonsen LB; Carstensen B; Nilsson A; Lernmark Å; Pociot F; Johannesen J;
Hum Immunol; 2012 Nov; 73(11):1116-26. PubMed ID: 22906888
[TBL] [Abstract][Full Text] [Related]
4. Assessment of chemokine serum levels in epithelial ovarian cancer patients.
Falcão-Júnior JO; Teixeira-Carvalho A; Cândido EB; Lages EL; Ferreira Freitas G G; Lamaita RM; Freire Bonfim LP; Borges Salera R; Traiman P P; da Silva-Filho AL
Tumori; 2013; 99(4):540-4. PubMed ID: 24326845
[TBL] [Abstract][Full Text] [Related]
5. Differences in MBL levels between juvenile patients newly diagnosed with type 1 diabetes and their healthy siblings.
Sildorf SM; Eising S; Hougaard DM; Mortensen HB; Skogstrand K; Pociot F; Johannesen J; Svensson J
Mol Immunol; 2014 Nov; 62(1):71-6. PubMed ID: 24972325
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies to CCL3 are of low sensitivity and specificity for the diagnosis of type 1 diabetes.
Huang G; Mo X; Li M; Xiang Y; Li X; Luo S; Zhou Z
Acta Diabetol; 2012 Oct; 49(5):395-9. PubMed ID: 22350136
[TBL] [Abstract][Full Text] [Related]
7. The urokinase-type plasminogen activator/its soluble receptor system is independently related to carotid atherosclerosis and associated with CC-chemokines in uraemic patients.
Pawlak K; Mysliwiec M; Pawlak D
Thromb Res; 2008; 122(3):328-35. PubMed ID: 18048089
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of chemokines, risk of stable coronary heart disease, and correlation with established cardiovascular risk markers.
Rothenbacher D; Müller-Scholze S; Herder C; Koenig W; Kolb H
Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):194-9. PubMed ID: 16239601
[TBL] [Abstract][Full Text] [Related]
9. Molecular signatures differentiate immune states in type 1 diabetic families.
Chen YG; Cabrera SM; Jia S; Kaldunski ML; Kramer J; Cheong S; Geoffrey R; Roethle MF; Woodliff JE; Greenbaum CJ; Wang X; Hessner MJ
Diabetes; 2014 Nov; 63(11):3960-73. PubMed ID: 24760139
[TBL] [Abstract][Full Text] [Related]
10. CCL2, CCL3 and CCL5 chemokines in systemic sclerosis: the correlation with SSc clinical features and the effect of prostaglandin E1 treatment.
Bandinelli F; Del Rosso A; Gabrielli A; Giacomelli R; Bartoli F; Guiducci S; Matucci Cerinic M
Clin Exp Rheumatol; 2012; 30(2 Suppl 71):S44-9. PubMed ID: 22691208
[TBL] [Abstract][Full Text] [Related]
11. Adiponectin stimulates release of CCL2, -3, -4 and -5 while the surface abundance of CCR2 and -5 is simultaneously reduced in primary human monocytes.
Neumeier M; Bauer S; Brühl H; Eisinger K; Kopp A; Abke S; Walter R; Schäffler A; Buechler C
Cytokine; 2011 Dec; 56(3):573-80. PubMed ID: 21890375
[TBL] [Abstract][Full Text] [Related]
12. The relationship between chemokines CCL2, CCL3, and CCL4 with the tumor microenvironment and tumor-associated macrophage markers in colorectal cancer.
De la Fuente López M; Landskron G; Parada D; Dubois-Camacho K; Simian D; Martinez M; Romero D; Roa JC; Chahuán I; Gutiérrez R; Lopez-K F; Alvarez K; Kronberg U; López S; Sanguinetti A; Moreno N; Abedrapo M; González MJ; Quera R; Hermoso-R MA
Tumour Biol; 2018 Nov; 40(11):1010428318810059. PubMed ID: 30419802
[TBL] [Abstract][Full Text] [Related]
13. Large-Scale Discovery and Validation Studies Demonstrate Significant Reductions in Circulating Levels of IL8, IL-1Ra, MCP-1, and MIP-1β in Patients With Type 1 Diabetes.
Purohit S; Sharma A; Hopkins D; Steed L; Bode B; Anderson SW; Reed JC; Steed RD; Yang T; She JX
J Clin Endocrinol Metab; 2015 Sep; 100(9):E1179-87. PubMed ID: 26158606
[TBL] [Abstract][Full Text] [Related]
14. Serum Th1 (CXCL10) and Th2 (CCL2) chemokine levels in children with newly diagnosed Type 1 diabetes: a longitudinal study.
Antonelli A; Fallahi P; Ferrari SM; Pupilli C; d'Annunzio G; Lorini R; Vanelli M; Ferrannini E
Diabet Med; 2008 Nov; 25(11):1349-53. PubMed ID: 19046227
[TBL] [Abstract][Full Text] [Related]
15. High levels of immunoglobulin E and a continuous increase in immunoglobulin G and immunoglobulin M by age in children with newly diagnosed type 1 diabetes.
Svensson J; Eising S; Mortensen HB; Christiansen M; Laursen I; Lernmark Å; Nilsson A; Simonsen LB; Carstensen B; Pociot F; Johannesen J;
Hum Immunol; 2012 Jan; 73(1):17-25. PubMed ID: 22057035
[TBL] [Abstract][Full Text] [Related]
16. Serial measurements of levels of the chemokines CCL2, CCL3 and CCL5 in serum of patients with acute ischaemic stroke.
Zaremba J; Ilkowski J; Losy J
Folia Neuropathol; 2006; 44(4):282-9. PubMed ID: 17183455
[TBL] [Abstract][Full Text] [Related]
17. Adiponectin-induced secretion of interleukin-6 (IL-6), monocyte chemotactic protein-1 (MCP-1, CCL2) and interleukin-8 (IL-8, CXCL8) is impaired in monocytes from patients with type I diabetes.
Abke S; Neumeier M; Weigert J; Wehrwein G; Eggenhofer E; Schäffler A; Maier K; Aslanidis C; Schölmerich J; Buechler C
Cardiovasc Diabetol; 2006 Aug; 5():17. PubMed ID: 16939660
[TBL] [Abstract][Full Text] [Related]
18. Differential patterns of 27 cord blood immune biomarkers across gestational age.
Matoba N; Yu Y; Mestan K; Pearson C; Ortiz K; Porta N; Thorsen P; Skogstrand K; Hougaard DM; Zuckerman B; Wang X
Pediatrics; 2009 May; 123(5):1320-8. PubMed ID: 19403498
[TBL] [Abstract][Full Text] [Related]
19. Kinetics of chemokines in acute myocardial infarction.
Kobusiak-Prokopowicz M; Orzeszko J; Mazur G; Mysiak A; Orda A; Mazurek W
Kardiol Pol; 2005 Apr; 62(4):301-14; discussion 315-6. PubMed ID: 15928736
[TBL] [Abstract][Full Text] [Related]
20. A rapid chemokine response of macrophage inflammatory protein (MIP)-1α, MIP-1β and the regulated on activation, normal T expressed and secreted chemokine is associated with a sustained virological response in the treatment of chronic hepatitis C.
Florholmen J; Kristiansen MG; Steigen SE; Sørbye SW; Paulssen EJ; Kvamme JM; Konopski Z; Gutteberg T; Goll R
Clin Microbiol Infect; 2011 Feb; 17(2):204-9. PubMed ID: 20219081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
